HEDS is part of the School of Health and Related Research (ScHARR) at the University of Sheffield. We undertake research, teaching, training and consultancy on all aspects of health related decision science, with a particular emphasis on health economics, HTA and evidence synthesis.

Thursday, 19 May 2011

Recent CUAs

Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 27 papers were listed this time. Here's a handful in our areas of our research interest:

Yang KY, Caughey AB, Little SE, et al. A cost-effectiveness analysis of prophylactic surgery versus gynecologic surveillance for women from hereditary non-polyposis colorectal cancer (HNPCC) Families. Fam Cancer. 2011 May 3. [Epub ahead of print] PubMed PMID: 21538078.

Gillespie P, O'Shea E, Murphy AW, et al; for the SPHERE study team. Relative cost effectiveness of the SPHERE intervention in selected patient subgroups with existing coronary heart disease. Eur J Health Econ. 2011 May 3. [Epub ahead of print] PubMed PMID: 21537952.

Soini EJ, Martikainen JA, Nousiainen T. Treatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up. Ann Oncol. 2011 May;22(5):1189-97. PMID: 21135053

Nagy B, Brennan A, Brandtm├╝ller A, Thomas SK, Sullivan SD, Akehurst R. Assessing the cost-effectiveness of the rivastigmine transdermal patch for Alzheimer's disease in the UK using MMSE- and ADL-based models. Int J Geriatr Psychiatry. 2011 May;26(5):483-94. PMID: 20845395.